sepsis
T2 Biosystems Preliminary Q3 Revenues up 33 Percent; Reaches Deal With Cardinal Health
The firm executed contracts for 11 T2Dx instruments in the quarter and saw its sepsis test panel revenue increase 42 percent.
New England Hemolytics Gets $275K NSF Grant to Develop Pathogen DNA Extraction System
The company aims to test the system's ability to extract DNA from bacterial and fungal pathogens that cause sepsis.
Inflammatix Raises $57M in Series E Financing
The company said that it will use the money to support regulatory filings and commercialization of its 30-minute TriVerity Acute Infection and Sepsis Test.
Building on previous research, the team has developed the test and implemented it clinically throughout Europe.
Sepsis Study Untangles Genetic Variants, Regulatory Features Behind High-Risk Subgroup
With genotyping and gene expression data for adult sepsis patients enrolled over more than a decade, researchers explored genetic variation and regulation behind the condition.
Apr 29, 2024
Mar 21, 2024
Presymptom Health Raises £1.5M for Sepsis Test
Nov 28, 2023
Feb 1, 2023
Jan 17, 2023